EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Cyclosporine and itraconazole interaction in heart and lung transplant recipients



Cyclosporine and itraconazole interaction in heart and lung transplant recipients



Annals of Internal Medicine 113(4): 327-329




(PDF emailed within 0-6 h: $19.90)

Accession: 001790969

Download citation: RISBibTeXText

PMID: 2165371

DOI: 10.7326/0003-4819-113-4-327



Related references

Enhanced cyclosporine-itraconazole interaction with cola in lung transplant recipients. Clinical Transplantation 15(2): 116-122, 2001

Enhanced cyclosporine -itraconazole interaction with cola in lung transplant recipients. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 39: 4, 1999

Beneficial pharmacokinetic interaction between cyclosporine and itraconazole in renal transplant recipients. Transplantation Proceedings 35(8): 2873-2877, 2003

Pharmacodynamics of cyclosporine in heart and heart-lung transplant recipients. II: Blood cyclosporine concentrations and other risk factors for lung allograft rejection. Transplantation 62(10): 1436-1441, 1996

Blood concentration curve of cyclosporine: impact of itraconazole in lung transplant recipients. Transplantation 83(8): 1130-1133, 2007

Dose adjustment and cost of itraconazole prophylaxis in lung transplant recipients receiving cyclosporine and tacrolimus (FK 506). Transplantation Proceedings 29(6): 2657-2659, 1997

Pharmacodynamics of cyclosporine in heart and heart-lung transplant recipients. I: Blood cyclosporine concentrations and other risk factors for cardiac allograft rejection. Transplantation 62(10): 1429-1435, 1996

Voriconazole and itraconazole in lung transplant recipients receiving tacrolimus (FK 506): efficacy and drug interaction. Clinical Transplantation 25(2): E163-E167, 2011

Itraconazole prophylaxis in lung transplant recipients receiving tacrolimus (FK 506): efficacy and drug interaction. Journal of Heart and Lung Transplantation 24(12): 2148-2152, 2005

Fungal infection in heart-lung transplant recipients receiving single-agent prophylaxis with itraconazole. Experimental and Clinical Transplantation 9(6): 399-404, 2012

A drug interaction study between ticlopidine and cyclosporine in heart transplant recipients. European Journal of Clinical Pharmacology 53(1): 39-45, 1997

Interaction between tacrolimus and itraconazole in a heart-lung transplant recipient. Transplantation Proceedings 30(1): 187-188, 1998

Risks and benefits of withdrawing cyclosporine from the long-term immunosuppression regimen of heart and heart-lung transplant recipients. Transplantation Proceedings 30(4): 1149-1151, 1998

Plasma free fraction of cyclosporine in heart and lung transplant recipients. Journal of Heart & Lung Transplantation 16(1): 77, 1997